These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 19663842)
1. Characterization of the inflammatory cell infiltrate in herald patches and fully developed eruptions of pityriasis rosea. Neoh CY; Tan AW; Mohamed K; Sun YJ; Tan SH Clin Exp Dermatol; 2010 Apr; 35(3):300-4. PubMed ID: 19663842 [TBL] [Abstract][Full Text] [Related]
2. Subsets of T lymphocytes in the lesional skin of pityriasis rosea. Wang S; Fu L; Du W; Hu J; Zha Y; Wang P An Bras Dermatol; 2019; 94(1):52-55. PubMed ID: 30726464 [TBL] [Abstract][Full Text] [Related]
3. A clinicoepidemiological study of pityriasis rosea in South India. Ganguly S Skinmed; 2013; 11(3):141-6. PubMed ID: 23930352 [TBL] [Abstract][Full Text] [Related]
4. Phenotypical characteristics of the immune cells in allergic contact dermatitis, atopic dermatitis and pityriasis rosea. Hussein MR; Abdel-Magid WM; Saleh R; Nada E Pathol Oncol Res; 2009 Mar; 15(1):73-9. PubMed ID: 18798012 [TBL] [Abstract][Full Text] [Related]
7. Pityriasis rosea (Gibert): abnormal distribution pattern of antigen presenting cells in situ. Bos JD; Huisman PM; Krieg SR; Faber WR Acta Derm Venereol; 1985; 65(2):132-7. PubMed ID: 2408415 [TBL] [Abstract][Full Text] [Related]
8. Pityriasis rosea: an important papulosquamous disorder. González LM; Allen R; Janniger CK; Schwartz RA Int J Dermatol; 2005 Sep; 44(9):757-64. PubMed ID: 16135147 [No Abstract] [Full Text] [Related]
9. The role of interleukin-22 in pityriasis rosea. Al Mokadem S; Ghonemy S; Zidan A; Abd El Aleem G Clin Exp Dermatol; 2017 Jan; 42(1):30-35. PubMed ID: 27862158 [TBL] [Abstract][Full Text] [Related]
10. An update on pityriasis rosea and other similar childhood exanthems. Browning JC Curr Opin Pediatr; 2009 Aug; 21(4):481-5. PubMed ID: 19502983 [TBL] [Abstract][Full Text] [Related]
11. Pityriasis Rosea Recurrence is Much Higher than Previously Known: A Prospective Study. Yüksel M Acta Derm Venereol; 2019 Jun; 99(7):664-667. PubMed ID: 30848285 [TBL] [Abstract][Full Text] [Related]
16. Pityriasis rosea-like adverse reaction: review of the literature and experience of an Italian drug-surveillance center. Atzori L; Pinna AL; Ferreli C; Aste N Dermatol Online J; 2006 Jan; 12(1):1. PubMed ID: 16638369 [TBL] [Abstract][Full Text] [Related]
17. Palmar herald patch in pityriasis rosea. Polat M; Yildirim Y; Makara A Australas J Dermatol; 2012 Aug; 53(3):e64-5. PubMed ID: 22881477 [TBL] [Abstract][Full Text] [Related]
19. Low dose of acyclovir may be an effective treatment against pityriasis rosea: a random investigator-blind clinical trial on 64 patients. Rassai S; Feily A; Sina N; Abtahian S J Eur Acad Dermatol Venereol; 2011 Jan; 25(1):24-6. PubMed ID: 20477925 [TBL] [Abstract][Full Text] [Related]
20. Tongue and cheek: oral lesions in pityriasis rosea. Vidimos AT; Camisa C Cutis; 1992 Oct; 50(4):276-80. PubMed ID: 1424793 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]